Suppressing the OTUD7A/KDM5B/GABPA axis enhances the sensitivity of cisplatin through inducing ferroptosis in KRAS-mutant LUAD
Open Access
- 20 December 2025
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Abstract
KRAS-mutant lung adenocarcinoma (LUAD), due to its evolution of more complex antioxidant metabolic mechanisms, exhibits poorer sensitivity to conventional platinum-based drugs compared to other types of LUAD. Ferroptosis, as a means of inducing cell death in cancer therapy, shows unique features and potential therapeutic effects compared to the conventional form of apoptosis, which is frequently obstructed by drug resistance. In human KRAS-mutant LUAD cell lines and mouse models, we found that the deubiquitinase OTU deubiquitinase 7A (OTUD7A) precisely regulates the lysine demethylase 5B (KDM5B). Inhibition of KDM5B expression increases the H4K20me3 level, which in turn downregulates the expression of transcription factor GABPA associated with mitochondrial function, ultimately promoting the production of more Reactive Oxygen Species (ROS) by mitochondria and inducing ferroptosis. Additionally, in in vivo organoid models, cisplatin (CDDP) induced ferroptosis combined with GABPA inhibition demonstrated superior anticancer effects compared to conventional platinum-based drugs. This research identifies new targets and regulatory networks that hold promise for developing ferroptosis-based therapies for KRAS-mutant LUAD.Keywords
Funding Information
- National Natural Science Foundation of China (82272863)
- Nanjing Medical University (2024KF0228)
- the Yishan Research Project of Jiangsu Cancer Hospital
This publication has 61 references indexed in Scilit:
- Unraveling the NRF2 confusion: Distinguishing nuclear respiratory factor 2 from nuclear erythroid factor 2Ageing Research Reviews, 2024
- EZH2 Inhibition Enhances PD‐L1 Protein Stability Through USP22‐Mediated Deubiquitination in Colorectal CancerAdvanced Science, 2024
- Metabolic switch regulates lineage plasticity and induces synthetic lethality in triple-negative breast cancerCell Metabolism, 2024
- FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent mannerJournal of Advanced Research, 2023
- Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2023
- Metabolic adaptation in hypoxia and cancerCancer Letters, 2021
- Ferroptosis: An emerging therapeutic opportunity for cancerGenes & Diseases, 2020
- OTUD7A Regulates Neurodevelopmental Phenotypes in the 15q13.3 Microdeletion SyndromeThe American Journal of Human Genetics, 2018
- Deubiquitination and Stabilization of PD-L1 by CSN5Cancer Cell, 2016
- Cancer Epigenetics: From Mechanism to TherapyCell, 2012